Beta

    when fda reclassify bpc-157 category 1

    Before September

    when fda reclassify bpc-157 category 1. Best Yes near 33¢ across 1 platform. Live cross-platform prices. Not financial advice.

    Best Yes: 33¢ · Best No: 73¢ · 1 platform

    • Kalshi: Yes 33¢ / No 73¢
    LIVE

    Before September

    Volume

    $11.9K

    $137 24h

    Platforms

    1

    Cross-platform pricing

    Resolution

    Resolves Sep 1, 2026

    ~77 days left

    Category

    Culture

    33¢CHANCE OF YES31%69%
    Yes
    33¢
    Kalshi
    No
    73¢
    Kalshi

    Opens on best-price platform

    Compare & Trade

    1 platform
    KalshiKalshi
    Best Yes
    Best No
    Yes
    33¢
    No
    73¢
    Vol
    $11.9K
    $137 24h
    Trade on Kalshi

    Price History

    Loading…

    About This Market

    If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes.

    Fee Impact at These Prices

    KalshiKalshiat 33¢: exit costs ~1.55¢/contract
    Full calculator

    Market Details

    ResolutionResolves Sep 1, 2026
    Time Left77 days
    Status● Active
    CategoryCulture

    Sign in to join the discussion

    Sign In